First-in-class ADC has benefit across mTNBC subgroupsDecember 14, 2020Breast CancerMetastatic Breast Cancer
Phase 1 study shows feasibility, safety, efficacy of STAR T cells for ALLDecember 14, 2020Lymphoma & Plasma Cell Disorders
Four factors may predict better survival with cabozantinib in mRCCDecember 14, 2020Renal Cell CarcinomaGenitourinary Cancer
CDC panel recommends Pfizer’s COVID-19 vaccine for people 16 and overDecember 12, 2020COVID-19 Updates
Pregnancy after breast cancer is rockier but doesn’t increase recurrence riskDecember 11, 2020Breast Cancer
Synthetic lethality: Triple combination is a viable strategy for B-cell malignanciesDecember 11, 2020DLBCLLymphoma & Plasma Cell Disorders
ZUMA-12 study shows frontline axi-cel has substantial activity in high-risk large B-cell lymphomaDecember 11, 2020Lymphoma & Plasma Cell Disorders
Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomabDecember 11, 2020Leukemia, Myelodysplasia, Transplantation
Breast cancer survival disparities: Need to address obesityDecember 11, 2020Breast CancerDiversity in Medicine
FDA panel overwhelmingly backs emergency authorization for Pfizer COVID vaccineDecember 10, 2020COVID-19 Updates
